Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $10.08 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.28.
Market Cap
10.08T
Revenue
4.74T
Profits
213.11B
PE Ratio
47.28
Profit Margin
4.50%
Dividend Yield
0.37%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.27T | -0.18% | 929,141 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 671.76B | -0.62% | 2,256,976 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 517.38B | -0.40% | 1,509,743 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 361.11B | -1.06% | 2,575,304 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 357.94B | -1.39% | 2,105,643 | 450.06B |
| 6 | NVS | Novartis AG | 294.52B | -2.17% | 1,195,200 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 283.86B | -1.06% | 865,532 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 267.39B | 0.48% | 1,083,693 | 47.35B |
| 9 | AMGN | Amgen Inc. | 250.88B | -0.31% | 780,157 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 210.14B | -0.85% | 1,711,289 | 30.99B |
| 11 | ABT | Abbott Laboratories | 190.38B | -0.49% | 2,942,465 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 179.37B | 0.47% | 7,082,468 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.01B | -0.20% | 11,266,645 | 63.62B |
| 14 | DHR | Danaher Corporation | 165.87B | -0.14% | 1,672,525 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.69B | -0.84% | 761,666 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 137.67B | -0.89% | 459,611 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.33B | -0.81% | 3,058,320 | 50.03B |
| 18 | MCK | McKesson Corporation | 123.94B | -0.84% | 191,405 | 418.79B |
| 19 | MDT | Medtronic plc | 123.80B | -0.45% | 1,875,099 | 37.54B |
| 20 | SYK | Stryker Corporation | 121.17B | -1.85% | 1,452,073 | 26.30B |
| 21 | SNY | Sanofi | 114.54B | -0.25% | 1,326,299 | 57.89B |
| 22 | CVS | CVS Health Corporation | 113.41B | -0.42% | 4,808,308 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 104.65B | -0.68% | 610,996 | 78.70B |
| 24 | GSK | GSK plc | 100.60B | -1.76% | 1,356,191 | 44.53B |
| 25 | MRNA | Moderna, Inc. | 100.27B | -1.21% | 4,595,608 | 2.53B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 94.94B | 3.28% | 624,398 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 91.91B | -0.99% | 287,758 | 201.83B |
| 28 | CI | The Cigna Group | 78.73B | -1.43% | 711,479 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 66.52B | -0.91% | 1,379,125 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.36B | -0.28% | 361,994 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 65.75B | 1.48% | 9,315,585 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 63.71B | -0.42% | 417,233 | 257.75B |
| 33 | ARGX | argenx SE | 61.10B | 0.59% | 128,863 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 60.33B | 0.87% | 1,430,926 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 57.94B | 0.06% | 679,775 | 19.46B |
| 36 | MDLN | Medline Inc. | 55.35B | 2.86% | 4,091,758 | 30.68B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 54.91B | 0.04% | 171,849 | 4.66B |
| 38 | HUM | Humana Inc. | 53.79B | 2.25% | 1,284,326 | 154.19B |
| 39 | A | Agilent Technologies, Inc. | 50.45B | 0.59% | 757,106 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 50.26B | 1.58% | 5,330,615 | 17.23B |
| 41 | VEEV | Veeva Systems Inc. | 49.80B | 0.67% | 517,433 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 48.03B | -0.84% | 265,494 | 6.45B |
| 43 | WAT | Waters Corporation | 46.55B | -0.36% | 273,371 | 5.61B |
| 44 | NTRA | Natera, Inc. | 46.31B | 2.38% | 958,969 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 45.86B | 1.13% | 602,884 | 17.31B |
| 46 | RPRX | Royalty Pharma plc | 39.99B | 0.37% | 1,905,039 | 2.62B |
| 47 | HLN | Haleon plc | 39.33B | 0.22% | 15,169,746 | 14.80B |
| 48 | RVMD | Revolution Medicines, Inc. | 39.29B | -5.92% | 1,889,261 | 197.56M |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.41B | -1.09% | 1,317,226 | 21.64B |
| 50 | BIIB | Biogen Inc. | 37.34B | -0.25% | 301,909 | 10.30B |
| 51 | ALC | Alcon Inc. | 35.22B | -2.69% | 3,460,324 | 10.98B |
| 52 | MTD | Mettler-Toledo International Inc. | 35.00B | 0.46% | 41,879 | 4.20B |
| 53 | CNC | Centene Corporation | 34.91B | 0.47% | 1,353,220 | 180.41B |
| 54 | GMAB | Genmab A/S | 33.40B | -1.18% | 2,221,658 | 4.30B |
| 55 | ZTS | Zoetis Inc. | 33.15B | -1.07% | 2,098,609 | 9.49B |
| 56 | RMD | ResMed Inc. | 33.08B | 0.47% | 302,463 | 5.73B |
| 57 | ILMN | Illumina, Inc. | 32.92B | 1.31% | 852,539 | 4.54B |
| 58 | ROIV | Roivant Sciences Ltd. | 30.39B | 1.82% | 3,237,374 | 41.08M |
| 59 | LH | Labcorp Holdings Inc. | 30.09B | -0.09% | 201,534 | 14.59B |
| 60 | DXCM | DexCom, Inc. | 29.90B | 0.32% | 1,609,065 | 5.10B |
| 61 | PHG | Koninklijke Philips N.V. | 29.24B | -0.89% | 1,072,145 | 20.16B |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.80B | 0.21% | 134,316 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.36B | -0.26% | 366,593 | 11.84B |
| 64 | INSM | Insmed Incorporated | 26.17B | -0.16% | 602,060 | 1.52B |
| 65 | UTHR | United Therapeutics Corporation | 25.40B | 1.33% | 145,184 | 3.19B |
| 66 | INCY | Incyte Corporation | 24.91B | 1.59% | 433,993 | 6.01B |
| 67 | STE | STERIS plc | 24.75B | -0.87% | 211,519 | 6.17B |
| 68 | VTRS | Viatris Inc. | 24.13B | 0.96% | 9,719,921 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.00B | -0.46% | 310,969 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.68B | 0.29% | 415,130 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.11B | 3.92% | 1,559,226 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 21.08B | 0.30% | 860,777 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.19B | -0.61% | 531,406 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.63B | 0.23% | 63,599 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.91B | 0.87% | 563,110 | 2.94B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 17.55B | 2.48% | 596,794 | 3.70B |
| 77 | EXEL | Exelixis, Inc. | 17.12B | -0.61% | 641,319 | 2.50B |
| 78 | ASND | Ascendis Pharma A/S | 16.86B | 0.03% | 280,756 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.75B | 1.09% | 262,397 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.81B | 0.36% | 290,353 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.40B | 0.48% | 929,249 | 945.54M |
| 82 | BTSG | BrightSpring Health Services, Inc. | 15.25B | 1.01% | 859,551 | 15.25B |
| 83 | SOLV | Solventum Corporation | 15.14B | -0.99% | 232,092 | 8.16B |
| 84 | ICLR | ICON Public Limited Company | 15.10B | -1.51% | 217,373 | 8.23B |
| 85 | TEM | Tempus AI, Inc. | 14.66B | -0.19% | 2,785,281 | 1.51B |
| 86 | GKOS | Glaukos Corporation | 14.53B | 4.01% | 434,284 | 690.33M |
| 87 | EHC | Encompass Health Corporation | 13.89B | -0.67% | 295,008 | 6.34B |
| 88 | BAX | Baxter International Inc. | 13.67B | 0.04% | 1,355,601 | 11.61B |
| 89 | SMMT | Summit Therapeutics Inc. | 13.44B | -5.72% | 2,479,443 | - |
| 90 | ELAN | Elanco Animal Health Incorporated | 13.22B | -1.20% | 1,487,554 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.72B | 0.16% | 636,748 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.68B | 0.10% | 197,156 | 1.56B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.12B | -0.87% | 1,118,681 | 3.44B |
| 94 | ALGN | Align Technology, Inc. | 12.04B | -1.96% | 422,737 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 11.97B | -0.98% | 652,167 | 4.24B |
| 96 | KYMR | Kymera Therapeutics, Inc. | 11.60B | -0.53% | 334,987 | 102.24M |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.56B | -1.54% | 1,299,946 | 1.80B |
| 98 | FMS | Fresenius Medical Care AG | 11.51B | -2.33% | 2,993,464 | 22.12B |
| 99 | TECH | Bio-Techne Corporation | 11.43B | -0.07% | 1,253,073 | 1.23B |
| 100 | DVA | DaVita Inc. | 11.28B | -0.03% | 230,291 | 14.17B |
| 101 | UHS | Universal Health Services, Inc. | 11.25B | -0.11% | 187,750 | 18.35B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 11.21B | 1.33% | 656,286 | 3.66B |
| 103 | RGEN | Repligen Corporation | 11.07B | -0.46% | 454,190 | 805.61M |
| 104 | MOH | Molina Healthcare, Inc. | 10.84B | 0.82% | 233,812 | 42.08B |
| 105 | PCVX | Vaxcyte, Inc. | 10.82B | 2.95% | 537,755 | - |
| 106 | AVTR | Avantor, Inc. | 10.69B | 1.35% | 2,420,077 | 6.64B |
| 107 | ENSG | The Ensign Group, Inc. | 10.68B | -0.25% | 111,602 | 5.67B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.42B | 0.21% | 89,062 | 2.59B |
| 109 | QGEN | Qiagen N.V. | 10.40B | -0.28% | 1,769,891 | 2.12B |
| 110 | PODD | Insulet Corporation | 10.33B | 0.60% | 507,358 | 3.19B |
| 111 | OSCR | Oscar Health, Inc. | 10.15B | -2.30% | 1,980,095 | 17.47B |
| 112 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.11B | 0.61% | 125,301 | 1.43B |
| 113 | SYRE | Spyre Therapeutics, Inc. | 10.09B | 1.69% | 421,980 | - |
| 114 | HNGE | Hinge Health, Inc. | 9.99B | -0.27% | 555,590 | 800.82M |
| 115 | GMED | Globus Medical, Inc. | 9.91B | -0.56% | 863,488 | 3.14B |
| 116 | PRAX | Praxis Precision Medicines, Inc. | 9.74B | 3.18% | 367,441 | 7.46M |
| 117 | HSIC | Henry Schein, Inc. | 9.72B | -0.90% | 389,963 | 13.73B |
| 118 | BRKR | Bruker Corporation | 9.51B | 0.08% | 1,076,268 | 3.51B |
| 119 | KRYS | Krystal Biotech, Inc. | 9.13B | 0.48% | 67,261 | 470.03M |
| 120 | ATR | AptarGroup, Inc. | 9.08B | -0.65% | 191,071 | 3.99B |
| 121 | MTRI | Mentari Therapeutics, Inc. | 9.01B | 22.87% | 40,385 | - |
| 122 | TGTX | TG Therapeutics, Inc. | 9.00B | -0.02% | 1,061,138 | 897.76M |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.76B | -1.49% | 166,782 | 551.69M |
| 124 | HQY | HealthEquity, Inc. | 8.53B | -0.42% | 274,814 | 1.36B |
| 125 | TXG | 10x Genomics, Inc. | 8.46B | 2.23% | 798,329 | 618.58M |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.14B | 1.38% | 531,600 | 963.65M |
| 127 | CYTK | Cytokinetics, Incorporated | 8.08B | 3.26% | 1,240,942 | 113.29M |
| 128 | PACS | PACS Group, Inc. | 8.01B | 2.81% | 490,844 | 5.71B |
| 129 | TWST | Twist Bioscience Corporation | 7.99B | -3.51% | 1,437,518 | 431.80M |
| 130 | ABVX | ABIVAX Société Anonyme | 7.98B | 2.22% | 473,824 | 5.33M |
| 131 | ALKS | Alkermes plc | 7.95B | 1.75% | 399,858 | 1.75B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.92B | 0.24% | 285,620 | 280.75M |
| 133 | AXSM | Axsome Therapeutics, Inc. | 7.84B | 5.77% | 627,677 | 865.27M |
| 134 | IMVT | Immunovant, Inc. | 7.67B | 3.81% | 712,305 | - |
| 135 | GRFS | Grifols, S.A. | 7.67B | 0.46% | 422,573 | 8.63B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 7.61B | 2.20% | 772,646 | 3.20B |
| 137 | BLCO | Bausch + Lomb Corporation | 7.61B | -0.42% | 293,521 | 5.42B |
| 138 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.48B | 0.13% | 306,593 | 945.96M |
| 139 | ORKA | Oruka Therapeutics, Inc. | 7.30B | -1.74% | 476,025 | - |
| 140 | CHE | Chemed Corporation | 7.08B | 0.30% | 32,913 | 2.66B |
| 141 | IBRX | ImmunityBio, Inc. | 7.05B | -1.70% | 8,401,456 | 182.57M |
| 142 | CAI | Caris Life Sciences, Inc. | 6.94B | -0.90% | 1,886,254 | 1.05B |
| 143 | KOD | Kodiak Sciences Inc. | 6.94B | 2.38% | 337,801 | - |
| 144 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.91B | -0.18% | 1,051,498 | 669.50M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.64B | -0.12% | 615,075 | 1.56B |
| 146 | CGON | CG Oncology, Inc. | 6.61B | 1.87% | 484,306 | 6.17M |
| 147 | MANE | Veradermics, Incorporated | 6.43B | 2.69% | 371,351 | - |
| 148 | BLTE | Belite Bio, Inc | 6.34B | 0.63% | 147,749 | - |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.34B | 0.93% | 42,515 | 253.83M |
| 150 | RDNT | RadNet, Inc. | 6.17B | 0.45% | 343,816 | 2.38B |
| 151 | TFX | Teleflex Incorporated | 6.14B | -0.24% | 269,568 | 2.26B |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 6.12B | -0.67% | 196,977 | 670.78M |
| 153 | SUPN | Supernus, Inc. | 6.11B | 2.33% | 1,529,593 | 1.37B |
| 154 | ERAS | Erasca, Inc. | 6.00B | 10.85% | 9,904,545 | - |
| 155 | DOCS | Doximity, Inc. | 5.94B | 2.68% | 886,950 | 661.58M |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.72B | -2.31% | 477,160 | 570.00K |
| 157 | GRAL | GRAIL, Inc. | 5.69B | 1.39% | 231,836 | 166.60M |
| 158 | WAY | Waystar Holding Corp. | 5.54B | -1.67% | 853,320 | 1.26B |
| 159 | HAE | Haemonetics Corporation | 5.52B | -0.88% | 150,265 | 1.38B |
| 160 | CON | Concentra Group Holdings Parent, Inc. | 5.48B | 1.43% | 278,023 | 2.34B |
| 161 | LFST | LifeStance Health Group, Inc. | 5.45B | -1.61% | 2,407,060 | 1.68B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.38B | 0.44% | 202,993 | 1.16B |
| 163 | BLLN | BillionToOne, Inc. | 5.28B | -1.35% | 426,089 | 436.87M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.26B | -0.09% | 169,084 | 1.61B |
| 165 | HTFL | HeartFlow, Inc. | 5.21B | 7.28% | 1,182,809 | 212.07M |
| 166 | COGT | Cogent Biosciences, Inc. | 5.20B | -5.53% | 2,608,970 | - |
| 167 | EWTX | Edgewise Therapeutics, Inc. | 5.19B | 1.89% | 722,472 | - |
| 168 | MMED | MiniMed Group, Inc. | 5.13B | 4.95% | 3,102,298 | 3.22B |
| 169 | ADPT | Adaptive Biotechnologies Corporation | 5.04B | 6.13% | 1,499,558 | 298.01M |
| 170 | LIVN | LivaNova PLC | 5.03B | 0.13% | 384,909 | 1.51B |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | 0.03% | 495,449 | 2.72M |
| 172 | TVTX | Travere Therapeutics, Inc. | 4.97B | -0.35% | 286,134 | 651.03M |
| 173 | LQDA | Liquidia Corporation | 4.94B | 6.61% | 2,276,886 | 621.87M |
| 174 | HIMS | Hims & Hers Health, Inc. | 4.83B | 7.74% | 15,948,629 | 2.87B |
| 175 | IONS | Ionis Pharmaceuticals, Inc. | 4.79B | 2.13% | 2,262,226 | 960.09M |
| 176 | OPCH | Option Care Health, Inc. | 4.74B | -0.03% | 2,374,165 | 5.75B |
| 177 | DFTX | Definium Therapeutics, Inc. | 4.73B | -0.23% | 686,642 | - |
| 178 | SHC | Sotera Health Company | 4.70B | 1.04% | 785,176 | 1.23B |
| 179 | ICUI | ICU Medical, Inc. | 4.46B | -2.13% | 131,549 | 2.18B |
| 180 | CRSP | CRISPR Therapeutics AG | 4.44B | 1.31% | 1,669,894 | 25.17M |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.38B | 6.34% | 2,322,516 | 53.81M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.38B | -0.65% | 906,703 | 10.35M |
| 183 | ITGR | Integer Holdings Corporation | 4.31B | 0.03% | 187,602 | 1.83B |
| 184 | CDNA | CareDx, Inc. | 4.27B | 0.53% | 398,577 | 497.40M |
| 185 | PLSE | Pulse Biosciences, Inc. | 4.13B | 1.78% | 168,501 | 1.49M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 4.10B | 0.68% | 546,677 | 7.50M |
| 187 | NVST | Envista Holdings Corporation | 4.08B | -1.47% | 695,200 | 2.88B |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.06B | 2.22% | 630,862 | -665.00K |
| 189 | ABCL | AbCellera Biologics Inc. | 3.96B | -2.01% | 1,672,917 | 67.85M |
| 190 | WRBY | Warby Parker Inc. | 3.91B | 5.28% | 2,348,162 | 934.66M |
| 191 | IRON | Disc Medicine, Inc. | 3.90B | 1.30% | 137,346 | - |
| 192 | STVN | Stevanato Group S.p.A. | 3.82B | 3.33% | 395,670 | 1.42B |
| 193 | ELVN | Enliven Therapeutics, Inc. | 3.78B | 0.21% | 266,136 | - |
| 194 | TARS | Tarsus Pharmaceuticals, Inc. | 3.76B | 3.30% | 218,562 | 682.20M |
| 195 | IOVA | Iovance Biotherapeutics, Inc. | 3.72B | -0.37% | 4,192,589 | 378.98M |
| 196 | LEGN | Legend Biotech Corporation | 3.72B | -6.08% | 2,644,659 | 1.36B |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.69B | -0.60% | 297,853 | 148.00K |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.67B | 0.52% | 1,440,017 | - |
| 199 | OGN | Organon & Co. | 3.65B | -0.07% | 1,087,430 | 6.10B |
| 200 | ACHC | Acadia Healthcare Company, Inc. | 3.61B | 0.62% | 739,816 | 3.41B |
| 201 | VRDN | Viridian Therapeutics, Inc. | 3.58B | 2.11% | 1,392,789 | 26.31M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.56B | 2.87% | 1,131,483 | 508.68M |
| 203 | SGRY | Surgery Partners, Inc. | 3.46B | -0.26% | 1,606,711 | 3.36B |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.40B | 1.34% | 897,774 | - |
| 205 | TLX | Telix Pharmaceuticals Limited | 3.36B | 3.07% | 167,473 | 890.79M |
| 206 | NHC | National HealthCare Corporation | 3.29B | 0.57% | 42,827 | 1.58B |
| 207 | CELC | Celcuity Inc. | 3.22B | -2.10% | 385,464 | - |
| 208 | AXGN | Axogen, Inc. | 3.21B | 5.62% | 1,304,516 | 266.93M |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 3.19B | 0.90% | 455,389 | 1.46B |
| 210 | ACAD | Acadia Pharmaceuticals Inc. | 3.18B | 0.66% | 1,187,009 | 1.20B |
| 211 | TMDX | TransMedics Group, Inc. | 3.18B | 0.61% | 433,532 | 727.65M |
| 212 | DNLI | Denali Therapeutics Inc. | 3.16B | -0.65% | 278,461 | 21.38M |
| 213 | BHC | Bausch Health Companies Inc. | 3.15B | 1.45% | 1,336,255 | 11.11B |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | 2.17% | 346,330 | 36.54M |
| 215 | PRVA | Privia Health Group, Inc. | 3.08B | -1.23% | 341,364 | 2.43B |
| 216 | XNCR | Xencor, Inc. | 3.02B | 2.11% | 541,304 | 200.49M |
| 217 | XERS | Xeris Biopharma Holdings, Inc. | 2.98B | 3.10% | 1,830,577 | 368.26M |
| 218 | VCEL | Vericel Corporation | 2.98B | -1.06% | 354,661 | 324.17M |
| 219 | IRTC | iRhythm Holdings, Inc. | 2.96B | 2.20% | 572,244 | 854.04M |
| 220 | ZLAB | Zai Lab Limited | 2.93B | -1.44% | 375,947 | 441.73M |
| 221 | ADMA | ADMA Biologics, Inc. | 2.89B | 2.96% | 1,094,967 | 519.15M |
| 222 | AVAH | Aveanna Healthcare Holdings Inc. | 2.86B | -0.61% | 587,030 | 2.60B |
| 223 | ATRC | AtriCure, Inc. | 2.86B | -0.34% | 203,420 | 589.80M |
| 224 | MBX | MBX Biosciences, Inc. | 2.82B | 0.73% | 257,089 | - |
| 225 | RGC | Regencell Bioscience Holdings Limited | 2.78B | 7.07% | 44,779 | - |
| 226 | RCUS | Arcus Biosciences, Inc. | 2.70B | 0.59% | 310,602 | 100.00M |
| 227 | CLOV | Clover Health Investments, Corp. | 2.67B | 1.12% | 2,561,699 | 2.74B |
| 228 | PGNY | Progyny, Inc. | 2.67B | -0.65% | 335,769 | 1.34B |
| 229 | HCM | HUTCHMED (China) Limited | 2.58B | -1.66% | 22,909 | 549.12M |
| 230 | BEAM | Beam Therapeutics Inc. | 2.56B | 2.19% | 871,936 | 146.64M |
| 231 | ARDT | Ardent Health, Inc. | 2.56B | 1.23% | 281,752 | 6.45B |
| 232 | NEOG | Neogen Corporation | 2.54B | -0.43% | 515,037 | 884.00M |
| 233 | NAMS | NewAmsterdam Pharma Company N.V. | 2.49B | 8.24% | 1,279,926 | 25.94M |
| 234 | UFPT | UFP Technologies, Inc. | 2.44B | 0.48% | 32,622 | 649.52M |
| 235 | SDGR | Schrödinger, Inc. | 2.44B | 0.28% | 1,251,694 | 269.20M |
| 236 | PVLA | Palvella Therapeutics, Inc. | 2.41B | -2.09% | 135,463 | - |
| 237 | PHVS | Pharvaris N.V. | 2.40B | 0.68% | 182,042 | - |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.39B | -0.62% | 259,802 | 158.00K |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.35B | -2.51% | 421,910 | 1.96B |
| 240 | PRGO | Perrigo Company plc | 2.31B | -1.31% | 449,696 | 4.09B |
| 241 | BHVN | Biohaven Ltd. | 2.30B | 0.63% | 572,009 | - |
| 242 | ADUS | Addus HomeCare Corporation | 2.28B | -1.18% | 97,398 | 1.50B |
| 243 | SEPN | Septerna, Inc. | 2.27B | -8.64% | 698,579 | 96.27M |
| 244 | IMNM | Immunome, Inc. | 2.26B | 2.49% | 457,918 | 4.02M |
| 245 | VIR | Vir Biotechnology, Inc. | 2.25B | 0.08% | 611,167 | 302.80M |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.23B | 0.70% | 10,719,517 | 68.23M |
| 247 | BKD | Brookdale Senior Living Inc. | 2.21B | -1.76% | 10,472,875 | 2.86B |
| 248 | VERA | Vera Therapeutics, Inc. | 2.19B | 1.00% | 816,850 | 10.28M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.19B | 2.34% | 544,997 | 1.08B |
| 250 | NEO | NeoGenomics, Inc. | 2.18B | -0.65% | 356,684 | 787.75M |
| 251 | ALMR | Alamar Biosciences, Inc. | 2.17B | -0.90% | 540,835 | 114.05M |
| 252 | REPL | Replimune Group, Inc. | 2.14B | -3.14% | 1,592,110 | - |
| 253 | ESTA | Establishment Labs Holdings Inc. | 2.12B | 5.83% | 183,845 | 264.03M |
| 254 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -2.88% | 591,677 | 321.74M |
| 255 | TRVI | Trevi Therapeutics, Inc. | 2.11B | -0.80% | 862,680 | - |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 2.10B | -4.64% | 260,064 | - |
| 257 | LKFT | Lakefront Biotherapeutics NV | 2.10B | -0.45% | 117,735 | 1.13B |
| 258 | PBH | Prestige Consumer Healthcare Inc. | 2.08B | -2.33% | 146,804 | 1.17B |
| 259 | AZTA | Azenta, Inc. | 2.08B | 23.12% | 1,025,650 | 621.70M |
| 260 | VCYT | Veracyte, Inc. | 2.04B | 5.15% | 1,684,488 | 581.78M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | -0.13% | 1,074,798 | 213.00M |
| 262 | FTRE | Fortrea Holdings Inc. | 2.03B | -1.59% | 523,930 | 2.67B |
| 263 | MAZE | Maze Therapeutics, Inc. | 2.03B | 4.68% | 248,194 | 20.00M |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | 1.79% | 407,350 | 989.36M |
| 265 | ZYME | Zymeworks Inc. | 2.01B | -7.66% | 416,766 | 265.97M |
| 266 | ETON | Eton Pharmaceuticals, Inc. | 1.99B | 2.13% | 550,271 | 141.06M |
| 267 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.97B | 1.59% | 1,207,597 | 961.51M |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | 2.96% | 280,009 | 140.84M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 1.95B | 0.56% | 139,650 | 11.00M |
| 270 | XRAY | DENTSPLY SIRONA Inc. | 1.94B | 0.98% | 3,385,594 | 3.58B |
| 271 | AGL | agilon health, inc. | 1.92B | 0.84% | 67,478 | 6.00B |
| 272 | KLRA | Kailera Therapeutics, Inc. | 1.86B | 0.49% | 190,763 | - |
| 273 | BFLY | Butterfly Network, Inc. | 1.86B | 6.61% | 2,365,080 | 123.26M |
| 274 | LYCA | Lycia Therapeutics, Inc. | 1.85B | 2.72% | 201,660 | 4.44M |
| 275 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | 1.42% | 323,135 | - |
| 276 | CERT | Certara, Inc. | 1.82B | -1.86% | 1,758,644 | 425.76M |
| 277 | KMTS | Kestra Medical Technologies, Ltd. | 1.81B | 2.77% | 113,040 | 106.73M |
| 278 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -0.13% | 52,990 | 269.36M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.80B | 4.03% | 1,347,941 | 701.94M |
| 280 | INSP | Inspire Medical Systems, Inc. | 1.78B | -1.30% | 255,423 | 880.94M |
| 281 | MESO | Mesoblast Limited | 1.78B | -1.57% | 66,836 | 120.25M |
| 282 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 0.85% | 941,950 | 1.96B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.78B | -0.26% | 355,188 | 28.21M |
| 284 | ALVO | Alvotech | 1.77B | 1.64% | 464,190 | 494.61M |
| 285 | GENB | Generate Biomedicines, Inc. | 1.76B | -0.29% | 212,366 | 26.48M |
| 286 | PSNL | Personalis, Inc. | 1.73B | 0.44% | 735,327 | 80.77M |
| 287 | ABSI | Absci Corporation | 1.71B | -0.20% | 3,262,365 | 1.56M |
| 288 | SLS | SELLAS Life Sciences Group, Inc. | 1.71B | 0.96% | 2,499,936 | - |
| 289 | HCSG | Healthcare Services Group, Inc. | 1.70B | -0.49% | 116,799 | 1.88B |
| 290 | PGEN | Precigen, Inc. | 1.70B | 4.65% | 1,888,615 | 156.94M |
| 291 | WGS | GeneDx Holdings Corp. | 1.69B | 3.10% | 489,128 | 460.78M |
| 292 | BRVE | Braveheart Bio, Inc. | 1.69B | 5.76% | 297,921 | - |
| 293 | RARE | Ultragenyx Pharmaceutical Inc. | 1.69B | 3.25% | 957,583 | 730.00M |
| 294 | ASTH | Astrana Health, Inc. | 1.68B | 2.04% | 94,468 | 3.91B |
| 295 | TDOC | Teladoc Health, Inc. | 1.66B | 1.79% | 1,679,476 | 2.47B |
| 296 | OMCL | Omnicell, Inc. | 1.66B | 0.36% | 159,315 | 1.24B |
| 297 | QURE | uniQure N.V. | 1.66B | 4.01% | 507,962 | 20.17M |
| 298 | NVAX | Novavax, Inc. | 1.65B | -2.06% | 3,482,399 | 411.65M |
| 299 | ENOV | Enovis Corporation | 1.65B | 1.24% | 429,310 | 2.31B |
| 300 | NBTX | Nanobiotix S.A. | 1.65B | 0.53% | 15,967 | 13.15M |
| 301 | IMCR | Immunocore Holdings plc | 1.64B | -1.74% | 186,116 | 429.30M |
| 302 | SNDA | Sonida Senior Living, Inc. | 1.63B | -0.44% | 143,191 | 593.56M |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 3.13% | 1,714,774 | 52.89M |
| 304 | ALHC | Alignment Healthcare, Inc. | 1.62B | 0.65% | 1,430,042 | 4.94B |
| 305 | RAPP | Rapport Therapeutics, Inc. | 1.56B | 1.69% | 202,505 | 20.00M |
| 306 | LMRI | Lumexa Imaging Holdings, Inc. | 1.54B | 14.80% | 618,149 | 1.06B |
| 307 | NUVB | Nuvation Bio Inc. | 1.53B | 3.10% | 1,326,684 | 201.73M |
| 308 | ADRX | ADARx Pharmaceuticals, Inc. | 1.52B | 0.22% | 301,077 | 6.13M |
| 309 | CNMD | CONMED Corporation | 1.52B | -0.61% | 62,653 | 1.37B |
| 310 | GPCR | Structure Therapeutics Inc. | 1.51B | -2.58% | 422,957 | - |
| 311 | DMRA | Damora Therapeutics, Inc. | 1.51B | 0.95% | 229,483 | - |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.50B | -0.32% | 193,046 | 1.04B |
| 313 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 0.60% | 73,057 | 829.86M |
| 314 | KARD | Kardigan, Inc. | 1.48B | 4.55% | 189,959 | - |
| 315 | AMN | AMN Healthcare Services, Inc. | 1.48B | 1.77% | 137,756 | 3.52B |
| 316 | KRSA | Korsana Biosciences, Inc. | 1.47B | 3.76% | 59,115 | - |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.46B | -0.04% | 250,693 | 743.30M |
| 318 | LBRX | LB Pharmaceuticals Inc | 1.46B | 0.28% | 139,736 | - |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.46B | 0.38% | 237,569 | - |
| 320 | ANAB | AnaptysBio, Inc. | 1.46B | 0.62% | 103,949 | 106.09M |
| 321 | OCUL | Ocular Therapeutix, Inc. | 1.45B | -0.15% | 1,433,313 | 50.38M |
| 322 | PAHC | Phibro Animal Health Corporation | 1.43B | 1.36% | 47,586 | 1.54B |
| 323 | MLYS | Mineralys Therapeutics, Inc. | 1.42B | 3.25% | 744,361 | - |
| 324 | NVCR | NovoCure Limited | 1.38B | 0.25% | 680,602 | 725.39M |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | -0.82% | 876,318 | 5.49M |
| 326 | AVLN | Avalyn Pharma Inc. | 1.38B | -0.11% | 167,975 | - |
| 327 | SVRA | Savara Inc. | 1.37B | 3.56% | 4,931,268 | - |
| 328 | MNKD | MannKind Corporation | 1.35B | -0.71% | 1,169,042 | 413.37M |
| 329 | INVA | Innoviva, Inc. | 1.34B | -1.47% | 272,122 | 438.32M |
| 330 | AAPG | Ascentage Pharma Group International | 1.33B | -2.48% | 6,563 | 94.61M |
| 331 | INBX | Inhibrx Biosciences, Inc. | 1.33B | -0.14% | 66,583 | 1.30M |
| 332 | PRCT | PROCEPT BioRobotics Corporation | 1.32B | -0.13% | 308,968 | 352.31M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.32B | 4.53% | 648,734 | - |
| 334 | TNDM | Tandem Diabetes Care, Inc. | 1.32B | 1.07% | 1,133,801 | 1.08B |
| 335 | NKTR | Nektar Therapeutics | 1.32B | 2.06% | 238,841 | 54.59M |
| 336 | GHRS | GH Research PLC | 1.32B | -2.04% | 57,976 | - |
| 337 | CMPS | COMPASS Pathways plc | 1.31B | 0.22% | 1,536,610 | - |
| 338 | STAA | STAAR Surgical Company | 1.31B | 9.51% | 498,853 | 328.27M |
| 339 | NUTX | Nutex Health Inc. | 1.31B | 2.29% | 69,417 | 796.53M |
| 340 | OMER | Omeros Corporation | 1.30B | 3.93% | 374,627 | 38.42M |
| 341 | PNTG | The Pennant Group, Inc. | 1.29B | -0.08% | 80,150 | 1.17B |
| 342 | CRON | Cronos Group Inc. | 1.28B | 1.17% | 713,524 | 206.20M |
| 343 | INNV | InnovAge Holding Corp. | 1.27B | -0.43% | 123,449 | 1.02B |
| 344 | URGN | UroGen Pharma Ltd. | 1.27B | 2.21% | 357,000 | 250.25M |
| 345 | VOR | Vor Biopharma Inc. | 1.24B | 3.27% | 143,766 | - |
| 346 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.24B | -0.14% | 220,362 | 745.79M |
| 347 | SLN | Silence Therapeutics plc | 1.23B | -0.10% | 192,840 | 615.00K |
| 348 | GDRX | GoodRx Holdings, Inc. | 1.23B | 1.69% | 430,392 | 785.23M |
| 349 | OPK | OPKO Health, Inc. | 1.22B | -4.09% | 1,181,363 | 654.10M |
| 350 | ANRO | Alto Neuroscience, Inc. | 1.21B | 5.35% | 396,381 | - |
| 351 | FRNM | Freenome, Inc. | 1.20B | 3.71% | 627,244 | 217.86M |
| 352 | MLTX | MoonLake Immunotherapeutics | 1.18B | 9.95% | 815,728 | - |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.17B | 3.58% | 457,532 | 1.66B |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.15B | 0.69% | 36,729 | - |
| 355 | AHG | Akso Health Group | 1.15B | 7.32% | 11,435 | 13.83M |
| 356 | VSTM | Verastem, Inc. | 1.13B | 3.09% | 1,255,848 | 100.30M |
| 357 | ATEC | Alphatec Holdings, Inc. | 1.13B | 4.43% | 3,278,126 | 839.72M |
| 358 | SIBN | SI-BONE, Inc. | 1.12B | -0.84% | 256,525 | 220.65M |
| 359 | SPTX | Seaport Therapeutics, Inc. | 1.12B | -4.73% | 134,635 | - |
| 360 | HROW | Harrow, Inc. | 1.12B | -2.14% | 545,273 | 303.25M |
| 361 | IRMD | IRADIMED CORPORATION | 1.10B | -0.60% | 35,744 | 89.34M |
| 362 | CBLL | CeriBell, Inc. | 1.07B | 0.47% | 108,104 | 108.72M |
| 363 | JBIO | Jade Biosciences, Inc. | 1.07B | 2.44% | 217,197 | - |
| 364 | GMRS | GMR Solutions Inc. | 1.06B | 7.01% | 1,398,069 | 5.97B |
| 365 | CSTL | Castle Biosciences, Inc. | 1.06B | -0.44% | 165,350 | 377.13M |
| 366 | AHCO | AdaptHealth Corp. | 1.04B | 0.45% | 1,034,801 | 3.44B |
| 367 | CTY | City Therapeutics, Inc. | 1.01B | 3.31% | 152,647 | 14.34M |
| 368 | ODTX | Odyssey Therapeutics, Inc. | 992.38M | 3.50% | 103,210 | 99.00K |
| 369 | AORT | Artivion, Inc. | 991.41M | -0.73% | 241,352 | 481.88M |
| 370 | AKTS | Aktis Oncology, Inc. | 973.34M | 0.29% | 62,875 | 10.06M |
| 371 | CRVS | Corvus Pharmaceuticals, Inc. | 966.69M | 0.79% | 464,948 | - |
| 372 | OMDA | Omada Health, Inc. | 964.69M | 3.25% | 549,377 | 333.04M |
| 373 | BBNX | Beta Bionics, Inc. | 964.47M | 7.38% | 485,022 | 127.27M |
| 374 | MGTX | MeiraGTx Holdings plc | 933.54M | 1.04% | 187,933 | 397.50M |
| 375 | BVS | Bioventus Inc. | 932.77M | -0.98% | 159,617 | 585.64M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 927.17M | 0.39% | 229,055 | - |
| 377 | LTGO | Latigo Biotherapeutics, Inc. | 922.89M | 4.43% | 111,634 | - |
| 378 | IMTX | Immatics N.V. | 919.24M | 4.75% | 614,253 | 49.33M |
| 379 | PHAR | Pharming Group N.V. | 906.09M | -1.66% | 11,969 | 386.75M |
| 380 | HSTM | HealthStream, Inc. | 889.89M | 1.18% | 131,954 | 327.95M |
| 381 | KIDS | OrthoPediatrics Corp. | 880.84M | 0.76% | 63,796 | 264.14M |
| 382 | SNDX | Syndax Pharmaceuticals, Inc. | 876.88M | 2.63% | 1,462,671 | 289.68M |
| 383 | IVA | Inventiva S.A. | 875.18M | -1.14% | 857,465 | 2.81M |
| 384 | GLUE | Monte Rosa Therapeutics, Inc. | 873.30M | -2.67% | 300,817 | 70.33M |
| 385 | BBTX | Bambusa Therapeutics, Inc. | 869.59M | 0.12% | 8,478 | - |
| 386 | ALMS | Alumis Inc. | 860.74M | 3.91% | 494,907 | 7.40M |
| 387 | SLDB | Solid Biosciences Inc. | 848.24M | 6.00% | 1,087,474 | - |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 837.04M | 1.08% | 1,233,278 | 38.54M |
| 389 | OBX | Obsidian Therapeutics, Inc. | 833.32M | -1.82% | 361,254 | - |
| 390 | RIGL | Rigel Pharmaceuticals, Inc. | 832.47M | 0.68% | 55,595 | 288.21M |
| 391 | IRWD | Ironwood Pharmaceuticals, Inc. | 811.20M | 1.87% | 1,409,819 | 400.30M |
| 392 | QDEL | QuidelOrtho Corporation | 805.51M | 1.91% | 702,933 | 2.59B |
| 393 | AURA | Aura Biosciences, Inc. | 799.81M | 0.46% | 377,579 | - |
| 394 | ANNX | Annexon, Inc. | 793.58M | -1.19% | 1,489,979 | - |
| 395 | PHR | Phreesia, Inc. | 793.27M | -2.67% | 365,658 | 507.79M |
| 396 | SGMT | Sagimet Biosciences Inc. | 789.92M | 2.30% | 907,241 | - |
| 397 | ATTO | Attovia Therapeutics, Inc. | 787.48M | 3.67% | 34,437 | 1.44M |
| 398 | INMD | InMode Ltd. | 780.59M | 2.37% | 498,789 | 373.60M |
| 399 | ARDX | Ardelyx, Inc. | 780.51M | 3.16% | 1,419,553 | 468.22M |
| 400 | VREX | Varex Imaging Corporation | 777.63M | - | 206,195 | 865.00M |
| 401 | DBVT | DBV Technologies S.A. | 765.27M | 2.87% | 209,759 | 3.74M |
| 402 | COLL | Collegium Pharmaceutical, Inc. | 763.52M | 0.41% | 213,860 | 815.19M |
| 403 | JANX | Janux Therapeutics, Inc. | 759.90M | 3.16% | 607,976 | 23.29M |
| 404 | CTKB | Cytek Biosciences, Inc. | 758.55M | 0.17% | 277,088 | 207.65M |
| 405 | DCTH | Delcath Systems, Inc. | 755.48M | 8.04% | 1,097,206 | 109.96M |
| 406 | PRME | Prime Medicine, Inc. | 754.31M | 8.72% | 9,977,005 | 4.07M |
| 407 | OABI | OmniAb, Inc. | 743.89M | - | 433,864 | 40.21M |
| 408 | CGEM | Cullinan Therapeutics, Inc. | 732.96M | 0.53% | 454,712 | - |
| 409 | KURA | Kura Oncology, Inc. | 730.44M | 5.02% | 2,188,238 | 79.31M |
| 410 | NVCT | Nuvectis Pharma, Inc. | 725.95M | 0.14% | 59,557 | - |
| 411 | CLYM | Climb Bio, Inc. | 724.83M | 5.11% | 857,136 | - |
| 412 | IAM | Iambic Therapeutics, Inc. | 724.28M | 3.38% | 231,456 | 18.25M |
| 413 | CADL | Candel Therapeutics, Inc. | 720.80M | 0.75% | 356,616 | - |
| 414 | FLGT | Fulgent Genetics, Inc. | 718.31M | -0.27% | 147,689 | 330.28M |
| 415 | ANL | Adlai Nortye Group Ltd. | 715.46M | 11.55% | 130,940 | 18.06M |
| 416 | BCAX | Bicara Therapeutics Inc. | 713.66M | 5.60% | 911,174 | - |
| 417 | DNA | Ginkgo Bioworks Holdings, Inc. | 710.40M | -8.74% | 1,603,952 | 130.75M |
| 418 | ZVRA | Zevra Therapeutics, Inc. | 709.59M | 0.04% | 343,935 | 147.76M |
| 419 | IMMX | Immix Biopharma, Inc. | 707.16M | 2.16% | 468,952 | - |
| 420 | AVBP | ArriVent BioPharma, Inc. | 700.33M | 0.37% | 382,915 | 5.00M |
| 421 | ACRS | Aclaris Therapeutics, Inc. | 694.72M | 5.54% | 898,076 | 6.40M |
| 422 | FDMT | 4D Molecular Therapeutics, Inc. | 692.76M | 0.64% | 190,847 | 92.01M |
| 423 | APMD | Apnimed, Inc. | 688.57M | 4.29% | 90,885 | 115.12M |
| 424 | HELP | Helus Pharma Inc. | 688.23M | 3.86% | 740,881 | - |
| 425 | SANA | Sana Biotechnology, Inc. | 684.67M | -5.97% | 1,517,904 | - |
| 426 | DSGN | Design Therapeutics, Inc. | 683.91M | 0.28% | 206,886 | - |
| 427 | WVE | Wave Life Sciences, Inc. | 674.52M | 0.29% | 737,416 | 70.92M |
| 428 | OLMA | Olema Pharmaceuticals, Inc. | 672.82M | 5.64% | 622,918 | - |
| 429 | SOPH | SOPHiA GENETICS SA | 668.99M | -0.64% | 614,830 | 90.97M |
| 430 | PACB | Pacific Biosciences of California, Inc. | 664.97M | -5.13% | 6,773,663 | 161.39M |
| 431 | GERN | Geron Corporation | 640.57M | 2.06% | 2,956,525 | 217.52M |
| 432 | EVO | Evotec SE | 623.20M | 0.59% | 46,527 | 815.72M |
| 433 | SRZN | Surrozen, Inc. | 614.55M | -1.23% | 74,937 | 10.53M |
| 434 | CAPR | Capricor Therapeutics, Inc. | 613.11M | 18.88% | 6,031,644 | 11.13M |
| 435 | CBIO | Crescent Biopharma, Inc. | 607.99M | 2.05% | 77,501 | 11.88M |
| 436 | SGHT | Sight Sciences, Inc. | 601.92M | 0.74% | 106,744 | 88.40M |
| 437 | TCMD | Tactile Systems Technology, Inc. | 600.13M | 0.64% | 75,149 | 356.42M |
| 438 | AVR | Anteris Technologies Global Corp. | 594.71M | 3.57% | 401,303 | 2.33M |
| 439 | ABUS | Arbutus Biopharma Corporation | 591.71M | 1.05% | 780,956 | 181.49M |
| 440 | SENS | Senseonics Holdings, Inc. | 579.03M | 5.38% | 851,657 | 60.01M |
| 441 | RGNX | REGENXBIO Inc. | 575.60M | 13.20% | 848,290 | 153.91M |
| 442 | NRC | NRC Health | 570.86M | 0.19% | 76,526 | 143.79M |
| 443 | ETRA | Electra Therapeutics, Inc. | 564.90M | 12.64% | 232,573 | - |
| 444 | ENTX | Entera Bio Ltd. | 558.29M | -0.93% | 64,857 | 42.00K |
| 445 | VALN | Valneva SE | 552.69M | 0.55% | 48,864 | 163.30M |
| 446 | TKNO | Alpha Teknova, Inc. | 552.29M | 0.57% | 181,476 | 45.95M |
| 447 | EVH | Evolent Health, Inc. | 549.69M | 1.25% | 775,254 | 2.34B |
| 448 | SRTA | Strata Critical Medical, Inc. | 547.98M | 1.91% | 535,664 | 280.76M |
| 449 | MYGN | Myriad Genetics, Inc. | 540.04M | -0.71% | 768,540 | 803.60M |
| 450 | RCEL | AVITA Medical, Inc. | 537.97M | -1.44% | 427,680 | 84.68M |
| 451 | EPRX | Eupraxia Pharmaceuticals Inc. | 536.87M | 6.55% | 348,688 | - |
| 452 | NGNE | Neurogene Inc. | 527.46M | 0.79% | 58,153 | 925.00K |
| 453 | DMAC | DiaMedica Therapeutics Inc. | 526.85M | 1.03% | 73,291 | - |
| 454 | OVID | Ovid Therapeutics Inc. | 520.90M | -1.43% | 1,383,902 | 1.45M |
| 455 | ANGO | AngioDynamics, Inc. | 516.01M | 1.66% | 217,878 | 325.38M |
| 456 | INDP | Indaptus Therapeutics, Inc. | 500.68M | 12.41% | 192,479 | - |
| 457 | STTK | Shattuck Labs, Inc. | 500.05M | 1.24% | 349,840 | 1.00M |
| 458 | CTEV | Claritev Corporation | 497.90M | 1.71% | 293,086 | 1.02B |
| 459 | BLSM | BlossomHill Therapeutics, Inc. | 497.12M | 9.83% | 95,732 | - |
| 460 | MDXG | MiMedx Group, Inc. | 494.69M | 0.59% | 573,493 | 303.73M |
| 461 | CARL | Carlsmed, Inc. | 489.44M | 21.41% | 399,786 | 71.78M |
| 462 | EOLS | Evolus, Inc. | 485.82M | 7.78% | 570,543 | 325.47M |
| 463 | MNPR | Monopar Therapeutics Inc. | 482.54M | 0.15% | 132,513 | - |
| 464 | PHAT | Phathom Pharmaceuticals, Inc. | 479.76M | 10.93% | 852,692 | 274.88M |
| 465 | OCS | Oculis Holding AG | 479.66M | 2.37% | 99,701 | 1.12M |
| 466 | OBIO | Orchestra BioMed Holdings, Inc. | 478.53M | 6.11% | 293,614 | 31.21M |
| 467 | AVTX | Avalo Therapeutics, Inc. | 476.46M | 15.08% | 1,056,394 | 59.00K |
| 468 | RLMD | Relmada Therapeutics, Inc. | 475.21M | 4.33% | 764,949 | - |
| 469 | GYRE | Gyre Therapeutics, Inc. | 475.02M | 2.60% | 68,072 | 110.06M |
| 470 | KMDA | Kamada Ltd. | 461.41M | -0.37% | 71,158 | 196.87M |
| 471 | CTMX | CytomX Therapeutics, Inc. | 461.08M | 6.82% | 2,715,658 | 14.03M |
| 472 | ASMB | Assembly Biosciences, Inc. | 456.99M | 5.13% | 110,566 | 74.85M |
| 473 | SI | Shoulder Innovations, Inc. | 455.69M | -0.68% | 100,199 | 64.49M |
| 474 | BWAY | BrainsWay Ltd. | 455.41M | 3.47% | 94,043 | 60.70M |
| 475 | ARVN | Arvinas, Inc. | 449.88M | -0.72% | 298,868 | 275.30M |
| 476 | PRTA | Prothena Corporation plc | 449.57M | 2.28% | 168,857 | 52.74M |
| 477 | AQST | Aquestive Therapeutics, Inc. | 448.08M | 1.28% | 1,359,916 | 48.84M |
| 478 | YDES | YD Bio Limited | 439.15M | 2.82% | 9,301 | 1.24M |
| 479 | STLN | Starling Oncology, Inc. | 432.44M | -2.30% | 1,911,360 | 620.45M |
| 480 | MOBI | Mobia Medical, Inc. | 430.93M | 5.98% | 152,679 | 51.89M |
| 481 | TECX | Tectonic Therapeutic, Inc. | 430.67M | 0.27% | 75,729 | - |
| 482 | IRD | Opus Genetics, Inc. | 429.15M | 4.96% | 664,126 | 7.91M |
| 483 | NPCE | NeuroPace, Inc. | 428.37M | -1.65% | 44,315 | 106.99M |
| 484 | MASS | 908 Devices Inc. | 428.30M | 3.15% | 324,386 | 65.79M |
| 485 | RZLT | Rezolute, Inc. | 428.01M | 1.49% | 504,811 | - |
| 486 | CTNM | Contineum Therapeutics, Inc. | 424.86M | 2.46% | 129,083 | - |
| 487 | CERS | Cerus Corporation | 423.09M | 7.44% | 1,220,738 | 226.57M |
| 488 | LYEL | Lyell Immunopharma, Inc. | 422.38M | 2.57% | 84,006 | 15.00K |
| 489 | MPLT | MapLight Therapeutics, Inc. | 422.38M | 2.15% | 117,178 | - |
| 490 | PBYI | Puma Biotechnology, Inc. | 418.76M | -0.49% | 143,681 | 231.83M |
| 491 | CRMD | CorMedix Inc. | 413.88M | -1.12% | 753,140 | 462.25M |
| 492 | ALEC | Alector, Inc. | 413.13M | 9.68% | 1,643,485 | 173.47M |
| 493 | PRLD | Prelude Therapeutics Incorporated | 399.62M | 3.19% | 157,169 | 22.42M |
| 494 | TLRY | Tilray Brands, Inc. | 390.12M | 0.38% | 4,069,266 | 963.10M |
| 495 | ASPE | Aspen Neuroscience, Inc. | 389.36M | 4.53% | 102,187 | - |
| 496 | SPRY | ARS Pharmaceuticals, Inc. | 383.01M | 6.72% | 1,392,671 | 122.14M |
| 497 | SLBT | SL Science Holding Limited | 382.08M | -25.47% | 284,634 | 3.27M |
| 498 | CCCC | C4 Therapeutics, Inc. | 380.82M | -3.33% | 1,172,522 | 32.28M |
| 499 | EDIT | Editas Medicine, Inc. | 375.82M | -2.79% | 1,077,079 | 49.83M |
| 500 | FENC | Fennec Pharmaceuticals Inc. | 374.52M | 0.95% | 124,180 | 59.22M |